IP Library Granted Patent US 11,236,874
Granted Patent B2
US 11,236,874 · App. 17/132,300 · Granted Feb 1, 2022

Beam shaping spectrally filtering optics and lighting devices using high-intensity narrow-spectrum light output

Inventor: Christopher Lane Bailey (Greenville, SC)
Assignee: Hubbell Incorporated
F21S8/086F21K9/65F21V5/04F21V7/0091F21V9/00F21V23/04G02B6/00H01L33/504H01L33/58H05B45/37F21W2131/103F21Y2113/13F21Y2115/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,236,874
App. No.
17/132,300
Granted
Feb 1, 2022
Kind
B2
Abstract

A lighting device includes a light source emitting light having a first bandwidth. A single optic device is coupled to the light source. The single optic device filters light having a preselected subrange of wavelengths within the first bandwidth to generate a first filtered light. The single optic device controls a shape of a beam of the filtered light. The filtered light creates a high-intensity narrow-spectrum light output. A second light source emits a high-intensity narrow-spectrum light output.

Claims (35)

1. A lighting device comprising:

a housing;

a first light source positioned in the housing, the first light source emitting light having a first bandwidth;

a single optic device coupled to the light source, wherein the single optic device filters light having a preselected subrange of wavelengths within the first bandwidth to generate a first filtered light, the single optic device controls a shape of a beam of the filtered light; and

a second light source positioned in the housing, the second light source emitting a high-intensity narrow-spectrum focused light output,

wherein the second light source is configured for medical sterilization.

2. The lighting device recited in claim 1 , wherein the single optic device is a free-form optic made of a material into which a filtering agent is disposed prior to forming the single optic device and the filtering agent filters the light having a preselected subrange of wavelengths.

3. The lighting device recited in claim 1 , wherein the high-intensity narrow-spectrum light output is between approximately 380-440 nanometers.

4. The lighting device recited in claim 3 , wherein the high-intensity narrow-spectrum light output is between approximately 400-420 nanometers.

5. The lighting device recited in claim 1 , wherein the high-intensity narrow-spectrum light output has a peak output of approximately 405 nanometers.

6. The lighting device recited in claim 1 , wherein the single optical device shifts light from within the first bandwidth to within a second bandwidth not included in the first bandwidth.

7. The lighting device recited in claim 1 , wherein said single optic device is a free-form optic made of a material into which a filtering agent is disposed prior to forming the single optic device and said filtering agent filters said light having a preselected subrange of wavelengths.

8. A method of making a lighting device comprising:

mixing a filtering agent with an optical material;

shaping the result of the mixing to form a filtering optic device;

coupling the filtering optic device to at least one LED that emits light waves in a first range of wavelengths, wherein the filtering agent filters light having a preselected subrange of wavelengths within the first range of wavelengths to generate a first filtered light and the filtering optic device controls a shape of a beam of the filtered light; and

combining the filtered light with a high-intensity narrow-spectrum focused light output to provide medical sterilization.

9. The method recited in claim 8 , wherein the filtering optic device is a TIR optic.

10. The method recited in claim 8 , wherein the filtering optic is only coupled to the LED.

11. The methods of claim 8 , wherein the high-intensity narrow-spectrum light output is in the range of approximately 380 to approximately 440 nanometers.

12. The methods of claim 11 , wherein the high-intensity narrow-spectrum light output is in the range of approximately 400 to approximately 420 nanometers.

13. The method recited in claim 8 , further comprising combining the filtering optic device with a non-filtering optic device within a luminaire device, wherein the non-filtering optic device does not include the filtering agent.

14. The method recited in claim 8 , wherein the filtering agent includes one or more of a dye, phosphors, fluorescing material and quantum dots.

15. A lighting device comprising:

a housing;

a first light source positioned in the housing, the first light source emitting light having a first bandwidth;

a second light source positioned in the housing, the second light source emitting light having a high-intensity narrow-spectrum focused light output, wherein the second light source is configured for medical sterilization;

a first optic device coupled to the first light source, wherein the first optic device filters light having a preselected subrange of wavelengths within the first bandwidth and generates a first filtered light;

a second optic device coupled to the second light source, wherein the second optic device permits the second bandwidth of light to pass through it unfiltered; and

a control device operably connected to the first and second light sources and operable to control whether light is emitted from one, both or neither of the first and second light sources.

16. The lighting device recited in claim 15 , wherein the control device is a wireless control device operable to control each of the first and second light sources via wireless control signals.

17. The lighting device recited in claim 15 , wherein the high-intensity narrow-spectrum light output corresponds to a range of wavelengths that can reduce or suppress bacterial pathogens.

18. The lighting device recited in claim 15 , wherein the high-intensity narrow-spectrum light output is between approximately 380-440 nanometers.

19. The lighting device recited in claim 18 , wherein the high-intensity narrow-spectrum light output is between approximately 400-420 nanometers.

20. The lighting device recited in claim 15 , wherein the high-intensity narrow-spectrum light output has a peak output of approximately 405 nanometers.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER PREVIOUSLY RECORDED AT REEL: 059034 FRAME: 0469. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jan 25, 2024
From: HUBBELL LIGHTING, INC.; LITECONTROL CORPORATION; CURRENT LIGHTING SOLUTIONS, LLC; DAINTREE NETWORKS INC.; FORUM, INC.
To: ATLANTIC PARK STRATEGIC CAPITAL FUND, L.P., AS COLLATERAL AGENT
Reel/Frame 066372/0590 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 10841994 TO PATENT NUMBER 11570872 PREVIOUSLY RECORDED ON REEL 058982 FRAME 0844. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Jan 19, 2024
From: HUBBELL LIGHTING, INC.; LITECONTROL CORPORATION; CURRENT LIGHTING SOLUTIONS, LLC; DAINTREE NETWORKS INC.; FORUM, INC.
To: ALLY BANK, AS COLLATERAL AGENT
Reel/Frame 066355/0455 →
SECURITY INTEREST Recorded Feb 11, 2022
From: HUBBELL LIGHTING, INC.; LITECONTROL CORPORATION; CURRENT LIGHTING SOLUTIONS, LLC; DAINTREE NETWORKS INC.; FORUM, INC.
To: ATLANTIC PARK STRATEGIC CAPITAL FUND, L.P., AS COLLATERAL AGENT
Reel/Frame 059034/0469 →
SECURITY AGREEMENT Recorded Feb 2, 2022
From: HUBBELL LIGHTING, INC.; LITECONTROL CORPORATION; CURRENT LIGHTING SOLUTIONS, LLC; DAINTREE NEETWORKS INC.; FORUM, INC.
To: ALLY BANK, AS COLLATERAL AGENT
Reel/Frame 058982/0844 →
NUNC PRO TUNC ASSIGNMENT Recorded Jan 25, 2022
From: HUBBELL INCORPORATED
To: HUBBELL LIGHTING, INC.
Reel/Frame 058838/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2020
From: BAILEY, CHRISTOPHER LANE
To: HUBBELL INCORPORATED
Reel/Frame 054738/0615 →
Continuity (3)
Continuation 16173743 · Oct 29, 2018
Provisional Application 62578714 · Oct 30, 2017
Related Publication 20210108769A1 · Apr 15, 2021